Ketorolac Mylan

Ketorolac Trometamol, the active ingredient in Ketorolac Mylan, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is employed for short‑term management of moderate to severe acute pain, including post‑operative pain, in adult patients when other analgesics are insufficient. GNH USA supplies Ketorolac Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Ketorolac Mylan is an NSAID that provides analgesia by inhibiting prostaglandin synthesis in acute pain states.

- Moderate to severe acute pain: delivers short‑term relief when opioid therapy is not required. - Post‑operative pain: reduces pain intensity after surgical procedures. - Dental pain: controls discomfort following dental extractions or oral surgery.

Ketorolac Mylan may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Dyspepsia or stomach upset. - Nausea and occasional vomiting. - Headache or dizziness. - Diarrhoea or constipation. - Mild elevation of serum creatinine.

Serious or Rare Side Effects: - Gastrointestinal bleeding, ulceration or perforation. - Severe renal impairment or acute kidney injury. - Anaphylactic or severe hypersensitivity reactions. - Hepatic dysfunction with elevated transaminases. - Thrombotic events such as myocardial infarction or stroke. - Skin reactions like Stevens‑Johnson syndrome.

When prescribing Ketorolac Mylan, clinicians should consider several safety measures.

- Assess renal function: avoid in patients with severe renal impairment. - Evaluate gastrointestinal risk: contraindicated in active peptic ulcer disease. - Use caution in the elderly: higher incidence of GI bleeding and renal effects. - Do not combine with other NSAIDs, anticoagulants, or antiplatelet agents without supervision. - Pregnancy and lactation: safety not established; avoid if possible. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ketorolac Mylan can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, DOACs): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Systemic corticosteroids: heightened ulcer risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in volume‑depleted patients. - Loop or thiazide diuretics: potential for renal impairment. - Lithium: NSAIDs can raise lithium serum concentrations, risking toxicity.